An Update on the Mechanisms of the Psychostimulant Effects of Caffeine
Open accessAbstract
There has been a long debate about the predominant involvement of the different adenosine receptor subtypes and the preferential role of pre‐ versus post‐synaptic mechanisms in the psychostimulant effects of the adenosine receptor antagonist caffeine. Both striatal A 1 and A 2A receptors are involved in the motor‐activating and probably reinforcing effects of caffeine, although they play a different role under conditions of acute or chronic caffeine administration. The present review emphasizes the key integrative role of adenosine and adenosine receptor heteromers in the computation of information at the level of the striatal spine module (SSM). This local module is mostly represented by the dendritic spine of the medium spiny neuron with its glutamatergic and dopaminergic synapses and astroglial processes that wrap the glutamatergic synapse. In the SSM, adenosine acts both pre‐ and post‐synaptically through multiple mechanisms, which depend on heteromerization of A 1 and A 2A receptors among themselves and with D 1 and D 2 receptors, respectively. A critical aspect of the mechanisms of the psychostimulant effects of caffeine is its ability to release the pre‐ and post‐synaptic brakes that adenosine imposes on dopaminergic neurotransmission by acting on different adenosine receptor heteromers localized in different elements of the SSM.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Caffeine's central stimulant effects likely arise from broader disinhibition of a multi-neurotransmitter network driven by concurrent antagonism of A1 and A2A receptors, rather than from blockade of a single receptor pathway alone.
“In addition, functional interactions between A2A receptors and dopaminergic signaling pathways suggest that caffeine’s central stimulant effects likely arise from the broader disinhibition of a multi-neurotransmitter network, driven by concurrent antagonism of A1 and A2A receptors, rather than from blockade of a single receptor pathway alone [37,38].”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [37]
The ‘Adenosine A1 or A2A receptor antagonism?’ section (page unavailable) concludes that both receptors contribute to caffeine’s motor-activating effects. The ‘Pre-synaptic mechanisms’ section (page unavailable) describes effects on dopamine and glutamate and says other neurotransmitters may also be involved. It does not establish broad disinhibition of a multi-neurotransmitter network as the mechanism; its account of receptor effects on neurotransmitter release is more varied. (LLM, conf=0.82)
Experimental — accuracy not yet measuredHigh concentrations of caffeine inhibit phosphodiesterase activity and stimulate dopamine D2 receptors.
“In addition, high concentrations of caffeine inhibit phosphodiesterase activity 3 and stimulate dopamine D2 receptors.9”
From Theanine maintains sleep quality in healthy young women by suppressing the increase in caffeine-induced wakefulness after sleep onset (2023) · cites this paper as [9]
Caffeine excites neural circuits that project from the basal ganglia to the striatum and cerebral cortex.
“Furthermore, caffeine excites neural circuits that project from the basal ganglia to the striatum and cerebral cortex.9”
From Theanine maintains sleep quality in healthy young women by suppressing the increase in caffeine-induced wakefulness after sleep onset (2023) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379 · see citing works
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · see citing works
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585 · see citing works
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb11000.x · Cited by 1,926 · see citing works
Ikemoto, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.004 · Cited by 1,477 · see citing works
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280 · see citing works
Mechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D. L., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,212 · see citing works
Plasma membrane monoamine transporters: structure, regulation and function
Torres, G. E., Gainetdinov, R. R., & Caron, M. G. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1008 · Cited by 936 · see citing works
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
Ledent, C. A., Vaugeois, J., Schiffmann, S. N., Pedrazzini, T., Yacoubi, M. E., Vanderhaeghen, J. J., Costentin, J., Heath, J. K., Vassart, G., & Parmentier, M. (1997) · Nature · doi:10.1038/41771 · Cited by 918 · see citing works
Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia
Ferré, S., Fuxé, K., Fredholm, B. B., Morelli, M., & Popoli, P. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01096-5 · Cited by 825 · see citing works
Self-citationRegulation of AMPA receptors during synaptic plasticity
Song, I., & Huganir, R. L. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02270-1 · Cited by 777 · see citing works
Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons
Surmeier, D. J., Song, W., & Yan, Z. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-20-06579.1996 · Cited by 747 · see citing works
Adenosine receptors and behavioral actions of methylxanthines.
Snyder, S. H., Katims, J. J., Annau, Z., Bruns, R. F., & Daly, J. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.3260 · Cited by 694 · see citing works
Food sources and intakes of caffeine in the diets of persons in the United States
Frary, C. D., Johnson, R. K., & Wang, M. Q. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.10.027 · Cited by 681 · see citing works
New roles for astrocytes: Regulation of synaptic transmission
Newman, E. A. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00237-6 · Cited by 619 · see citing works
PYCOCK, C. (1980) · Neuroscience · doi:10.1016/0306-4522(80)90048-2 · Cited by 610 · see citing works
Ciruela, F., Casadó, V., Rodrigues, R. J., Luján, R., Burgueño, J., Canals, M., Borycz, J., Rebola, N., Goldberg, S. R., Mallol, J., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3574-05.2006 · Cited by 591 · see citing works
Self-citationG-Protein-coupled receptor oligomerization and its potential for drug discovery
George, S. R., O’Dowd, B. F., & Lee, S. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd913 · Cited by 590 · see citing works
Adenosine and sleep–wake regulation
Basheer, R., Strecker, R. E., Thakkar, M. M., & McCarley, R. W. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.06.004 · Cited by 589 · see citing works
Juliano, L. M., & Griffiths, R. R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2000-x · Cited by 585 · see citing works
Ferré, S., von Euler, G., Johansson, B., Fredholm, B. B., & Fuxé, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7238 · Cited by 551 · see citing works
Self-citationCaffeine as a psychomotor stimulant: mechanism of action
Fisone, G., Borgkvist, A., & Usiello, A. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3269-3 · Cited by 539 · see citing works
Hillion, J., Canals, M., Torvinen, M., Casadó, V., Scott, R. P., Terasmaa, A., Hansson, A. C., Watson, S. J., Olah, M. E., Mallol, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107731200 · Cited by 499 · see citing works
Self-citationRashid, A. J., So, C. H., Kong, M. M. C., Furtak, T., El-Ghundi, M., Cheng, R., O’Dowd, B. F., & George, S. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604049104 · Cited by 492 · see citing works
Astrocytic control of glutamatergic activity: astrocytes as stars of the show
Hertz, L., & Zielke, H. R. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.10.008 · Cited by 470 · see citing works
Porkka‐Heiskanen, T., Strecker, R. E., & McCarley, R. W. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00220-7 · Cited by 463 · see citing works
Snyder, S. H. (1985) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.08.030185.000535 · Cited by 461 · see citing works
Are we dependent upon coffee and caffeine? A review on human and animal data
Nehlig, A. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00050-5 · Cited by 453 · see citing works
Dopamine D 1 and adenosine A 1 receptors form functionally interacting heteromeric complexes
Ginés, S., Hillion, J., Torvinen, M., Crom, S. L., Casadó, V., Canela, E. I., Rondin, S., Lew, J. Y., Watson, S. J., Zoli, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150241097 · Cited by 444 · see citing works
Self-citationHernández-López, S., Tkatch, T., Perez-Garci, E., Galarraga, E., Bargas, J., Hamm, H., & Surmeier, D. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-08987.2000 · Cited by 443 · see citing works
Valjent, E., Pagès, C., Hervé, D., Girault, J., & Caboche, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03278.x · Cited by 434 · see citing works
Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization
Canals, M., Marcellino, D. J., Fanelli, F., Ciruela, F., de Benedetti, P., Goldberg, S. R., Neve, K. A., Fuxé, K., Agnati, L. F., Woods, A. S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306451200 · Cited by 432 · see citing works
Self-citationFredholm, B. B., Irenius, E., Kull, B., & Schulte, G. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00570-0 · Cited by 430 · see citing works
Are Methylxanthine Effects Due to Antagonism of Endogenous Adenosine?
Fredholm, B. B. (1979) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(79)90046-4 · Cited by 409 · see citing works
Adenosine A2A receptors and basal ganglia physiology
Schiffmann, S. N., Fisone, G., Moresco, R. M., Cunha, R. A., & Ferré, S. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.05.001 · Cited by 393 · see citing works
Self-citationEffect of γ-butyrobetaine on fatty liver in juvenile visceral steatosis mice
Higashi, Y., Yokogawa, K., Takeuchi, N., Tamai, I., Nomura, M., Hashimoto, N., Hayakawa, J.-I., Miyamoto, K., & Tsuji, A. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775631 · Cited by 373 · see citing works
Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance
Prinster, S. C., Hague, C., & Hall, R. A. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.3.1 · Cited by 373 · see citing works
Adenosine-dopamine interactions in the brain
Ferré, S., Fuxé, K., von Euler, G., Johansson, B. A., & Fredholm, B. B. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90291-9 · Cited by 366 · see citing works
Self-citationFerré, S., Karcz‐Kubicha, M., Hope, B. T., Popoli, P., Burgueño, J., Gutiérrez, M. A., Casadó, V., Fuxé, K., Goldberg, S. R., Lluı́s, C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172393799 · Cited by 365 · see citing works
Self-citationLee, K.-W., Kim, Y. D., Kim, A. M., Helmin, K. A., Nairn, A. C., & Greengard, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511244103 · Cited by 354 · see citing works
Caffeine Induces Dopamine and Glutamate Release in the Shell of the Nucleus Accumbens
Solinas, M., Ferré, S., You, Z.-B., Karcz-Kubicha, M., Popoli, P., & Goldberg, S. R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06321.2002 · Cited by 338 · see citing works
Agnati, L. F., Ferré, S., Lluı́s, C., Franco, R., & Fuxé, K. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.2 · Cited by 322 · see citing works
Self-citationYacoubi, M. E., Ledent, C. A., Ménard, J.-F., Parmentier, M., Costentin, J., & Vaugeois, J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703170 · Cited by 307 · see citing works
Principles of Addiction Medicine
Matthews, A. (2004) · JAMA · doi:10.1001/jama.291.1.112-b · Cited by 278 · see citing works
Adenosine receptor ligands: differences with acute versus chronic treatment
Jacobson, K. A., Lubitz, D. K. J. E. V., Daly, J. W., & Fredholm, B. B. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10002-x · Cited by 263 · see citing works
Novel Neurotransmitters and Their Neuropsychiatric Relevance
Snyder, S. H., & Ferris, C. D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1738 · Cited by 262 · see citing works
Carriba, P., Ortiz, O., Patkar, K. A., Justinová, Z., Stroik, J., Themann, A., Müller, C. E., Woods, A. S., Hope, B. T., Ciruela, F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301375 · Cited by 260 · see citing works
Self-citationThe striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain
Ferré, S., O'Connor, W. T., Fuxé, K., & Ungerstedt, U. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-12-05402.1993 · Cited by 251 · see citing works
Self-citationEffects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation
James, J. E., & Rogers, P. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0084-6 · Cited by 231 · see citing works
The Role of Dopamine in the Behavioral Effects of Caffeine in Animals and Humans
Garrett, B. E., & Griffiths, R. R. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00435-2 · Cited by 226 · see citing works
Prostaglandins and adenosine in the regulation of sleep and wakefulness
Huang, Z., Urade, Y., & Hayaishi, O. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.09.004 · Cited by 224 · see citing works
Caffeine and the dopaminergic system
Cauli, O., & Morelli, M. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200503000-00001 · Cited by 196 · see citing works
Svenningsson, P., Lindskog, M., Ledent, C. A., Parmentier, M., Greengard, P., Fredholm, B. B., & Fisone, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1856 · Cited by 196 · see citing works
Karcz-Kubicha, M., Antoniou, K., Terasmaa, A., Quarta, D., Solinas, M., Justinova, Z., Pezzola, A., Reggio, R., Müller, C. E., Fuxe, K., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300167 · Cited by 189 · see citing works
Self-citationLeenders, A. G. M., & SHENG, Z. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.012 · Cited by 182 · see citing works
Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats
Popoli, P., Betto, P., Reggio, R., & Ricciarello, G. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00679-6 · Cited by 181 · see citing works
Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine
Lindskog, M., Svenningsson, P., Pozzi, L., Kim, Y. D., Fienberg, A. A., Bibb, J. A., Fredholm, B. B., Nairn, A. C., Greengard, P., & Fisone, G. (2002) · Nature · doi:10.1038/nature00817 · Cited by 180 · see citing works
8‐(3‐Chlorostyryl)caffeine (CSC) is a selective A2‐adenosine antagonist in vitro and in vivo
Jacobson, K. A., Nikodijević, O., Padgett, W. L., Gallo‐Rodriguez, C., Maillard, M. C., & Daly, J. W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81466-d · Cited by 173 · see citing works
Hervé, D., Moine, C. L., Corvol, J., Belluscio, L., Ledent, C. A., Fienberg, A. A., Jaber, M., Studler, J., & Girault, J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04390.2001 · Cited by 172 · see citing works
Fuxé, K., & Ungerstedt, U. (1974) · PubMed · Cited by 171 · see citing works
Svenningsson, P., Nomikos, G. G., Ongini, E., & Fredholm, B. B. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00046-8 · Cited by 170 · see citing works
Lupica, C. R., Cass, W. A., Zahniser, N. R., & Dunwiddie, T. V. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20171-9 · Cited by 169 · see citing works
Quarta, D., Ferré, S., Solinas, M., You, Z., Hockemeyer, J., Popoli, P., & Goldberg, S. R. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02245.x · Cited by 163 · see citing works
Self-citationImpaired D2 Dopamine Receptor Function in Mice Lacking Type 5 Adenylyl Cyclase
Lee, K.-W., Hong, J. H., Choi, I. Y., Che, Y., Lee, J.-K., Yang, S.-D., Song, C.-W., Kang, H. S., Lee, J.-H., Noh, J. S., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07931.2002 · Cited by 163 · see citing works
Anatomy of adenosine A2Areceptors in brain
Rosin, D. L., Hettinger, B. D., Lee, A., & Linden, J. M. (2003) · Neurology · doi:10.1212/01.wnl.0000095205.33940.99 · Cited by 162 · see citing works
Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum
Okada, M., Mizuno, K., & Kaneko, S. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12780-4 · Cited by 158 · see citing works
Functional relevance of neurotransmitter receptor heteromers in the central nervous system
Ferré, S., Ciruela, F., Woods, A. S., Lluı́s, C., & Franco, R. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.07.001 · Cited by 156 · see citing works
Self-citationRegulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors
Håkansson, K., Galdi, S., Hendrick, J. P., Snyder, G. L., Greengard, P., & Fisone, G. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03558.x · Cited by 156 · see citing works
Ferré, S., O'Connor, W. T., Svenningsson, P., Björklund, L., Lindberg, J., Tinner, B., Strömberg, I., Goldstein, M., Ögren, S. O., Ungerstedt, U., et al. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01617.x · Cited by 147 · see citing works
Self-citationJarvis, S. E., & Zamponi, G. W. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01800-9 · Cited by 143 · see citing works
Postsynaptic antagonistic interaction between adenosine A1, and dopamine D1 receptors
Ferré, S., Popoli, P., Giménez‐Llort, L., Finnman, U.-B., Martı́nez, E., de Carolis, A. S., & Fuxé, K. (1994) · Neuroreport · doi:10.1097/00001756-199412300-00020 · Cited by 138 · see citing works
Self-citationSolinas, M., Panlilio, L. V., Justinová, Z., Yaşar, S., & Goldberg, S. R. (2006) · Nature Protocols · doi:10.1038/nprot.2006.167 · Cited by 134 · see citing works
Metabotropic mGlu5 receptors regulate adenosine A 2A receptor signaling
Nishi, A., Liu, F., Matsuyama, S., Hamada, M., Higashi, H., Nairn, A. C., & Greengard, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237126100 · Cited by 134 · see citing works
Caffeine alters plasma adenosine levels
Conlay, L. A., Conant, J. A., deBros, F., & Wurtman, R. (1997) · Nature · doi:10.1038/38160 · Cited by 133 · see citing works
Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry
Ferré, S., Diamond, I., Goldberg, S. R., Yao, L., Hourani, S. M. O., Huang, Z., Urade, Y., & Kitchen, I. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.04.002 · Cited by 131 · see citing works
Self-citationAdenosine/dopamine interaction: implications for the treatment of Parkinson's disease
Ferré, S., Popoli, P., Giménez‐Llort, L., Rimondini, R., Müller, C. E., Strömberg, I., Ögren, S. O., & Fuxé, K. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00063-8 · Cited by 130 · see citing works
Self-citationOkada, M., Kiryu, K., 河田, 祐., Mizuno, K., Wada, K., Tasaki, H., & Kaneko, S. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00938-7 · Cited by 130 · see citing works
Reinforcing effects of caffeine in humans.
Griffiths, R. R., & Woodson, P. P. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21004-7 · Cited by 124 · see citing works
Adenosine Receptor Subtypes Modulate Two Major Functional Pathways for Hippocampal Serotonin Release
Okada, M., Nutt, D., Murakami, T., Zhu, G., 鎌田, 晃., 河田, 祐., & Kaneko, S. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00628.2001 · Cited by 121 · see citing works
Kull, B., Ferré, S., Arslan, G., Svenningsson, P., Fuxé, K., Owman, C., & Fredholm, B. B. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00184-7 · Cited by 121 · see citing works
Self-citationQuarta, D., Borycz, J., Solinas, M., Patkar, K. A., Hockemeyer, J., Ciruela, F., Lluı́s, C., Franco, R., Woods, A. S., Goldberg, S. R., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02761.x · Cited by 120 · see citing works
Self-citationBorycz, J., Pereira, M. F., Melani, A., Rodrigues, R. J., Köfalvi, A., Panlilio, L. V., Pedata, F., Goldberg, S. R., Cunha, R. A., & Ferré, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04386.x · Cited by 118 · see citing works
Self-citationFerré, S., Torvinen, M., Antoniou, K. M., Irenius, E., Civelli, O., Arenas, E., Fredholm, B. B., & Fuxé, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4718 · Cited by 117 · see citing works
Self-citationRole of adenosine receptors in caffeine tolerance.
Holtzman, S. G., Mante, S., & Minneman, K. P. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23061-0 · Cited by 114 · see citing works
Ferré, S., Agnati, L. F., Ciruela, F., Lluı́s, C., Woods, A. S., Fuxé, K., & Franco, R. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.01.007 · Cited by 113 · see citing works
Self-citationNehlig, A., & Boyet, S. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02480-4 · Cited by 105 · see citing works
Ferré, S., Herrera‐Marschitz, M., Grabowska‐Andén, M., Casas, M., Ungerstedt, U., & Andén, N. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90065-x · Cited by 105 · see citing works
Self-citationJiang, H., Jackson-Lewis, V. R., Muthane, U. B., Dollison, A. M., Ferreira, M., Espinosa, A., Parsons, B., & Przedborski, S. (1993) · Brain Research · doi:10.1016/0006-8993(93)90925-d · Cited by 99 · see citing works
Gubitz, A. K., Widdowson, L., Kurokawa, M., Kirkpatrick, K. A., & Richardson, P. J. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010374.x · Cited by 97 · see citing works
Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release
Zetterström, T., & Fillenz, M. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90601-2 · Cited by 94 · see citing works
Stanwood, G. D., Parlaman, J. P., & Levitt, P. R. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04970.x · Cited by 92 · see citing works
Mumford, G. K., & Holtzman, S. G. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20490-6 · Cited by 90 · see citing works
Blocking Striatal Adenosine A2A Receptors: A New Strategy for Basal Ganglia Disorders
Müller, C. E., & Ferré, S. (2007) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488907779561772 · Cited by 86 · see citing works
Self-citationStrömberg, I., Popoli, P., Müller, C. E., Ferré, S., & Fuxé, K. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00288.x · Cited by 85 · see citing works
Self-citationGerfen, C. R. (2004) · The Rat Nervous System · doi:10.1016/b978-012547638-6/50019-5 · Cited by 85 · see citing works
Halldner, L., Ådén, U., Dahlberg, V., Johansson, B. A., Ledent, C. A., & Fredholm, B. B. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.014 · Cited by 84 · see citing works
Durcan, M. J., & Morgan, P. F. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90789-9 · Cited by 80 · see citing works
Cocaine and Caffeine Conditioned Place Preference, Locomotor Activity, and Additivity
Bedingfield, J. B. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00092-6 · Cited by 79 · see citing works
Popoli, P., Giménez‐Llort, L., Pèzzola, A., Reggio, R., Martı́nez, E., Fuxé, K., & Ferré, S. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13143-8 · Cited by 74 · see citing works
Self-citationCorsi, C., Melani, A., Bianchi, L., & Pedata, F. (2000) · Neuroreport · doi:10.1097/00001756-200008030-00048 · Cited by 73 · see citing works
Shindou, T., Nonaka, H., Richardson, P. J., Mori, A., Kase, H., & Ichimura, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704702 · Cited by 71 · see citing works
Antoniou, K., Papadopoulou‐Daifoti, Z., Hyphantis, T. N., Papathanasiou, G., Bekris, E., Μαρσέλος, Μ., Panlilio, L. V., Müller, C. E., Goldberg, S. R., & Ferré, S. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0173-6 · Cited by 69 · see citing works
Self-citationPsychostimulants and monoamine transporters: upsetting the balance
Elliott, J. M., & Beveridge, T. J. R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.09.005 · Cited by 65 · see citing works
Popoli, P., Reggio, R., Pèzzola, A., Fuxé, K., & Ferré, S. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00533-3 · Cited by 62 · see citing works
Self-citationWood, P. L. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90062-2 · Cited by 60 · see citing works
Caffeine and accumbens shell dopamine
Luca, M. A. D., Bassareo, V., Bauer, A., & Chiara, G. D. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04754.x · Cited by 57 · see citing works
Lack of tolerance to motor stimulant effects of a selective adenosine A2A receptor antagonist
Halldner, L., Lozza, G., Lindström, K., & Fredholm, B. B. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00682-8 · Cited by 54 · see citing works
Caffeine place conditioning in rats: comparison with cocaine and ethanol
Patkina, N. A., & Zvartau, E. E. (1998) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00086-2 · Cited by 53 · see citing works
Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats
Solinas, M., Ferré, S., Antoniou, K. M., Quarta, D., Justinová, Z., Hockemeyer, J., Pappas, L. A., Segal, P. N., Wertheim, C. E., Müller, C. E., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2081-6 · Cited by 52 · see citing works
Self-citationROLE OF ADENOSINE IN THE CONTROL OF HOMOSYNAPTIC PLASTICITY IN STRIATAL EXCITATORY SYNAPSES
Ferré, S., Borycz, J., Goldberg, S. R., Hope, B. T., Morales, M., Lluı́s, C., Franco, R., Ciruela, F., & Cunha, R. A. (2005) · Journal of Integrative Neuroscience · doi:10.1142/s0219635205000987 · Cited by 50 · see citing works
Self-citationBallarín, M., Reiriz, J., Ambrosio, S., & Mahy, N. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11217-7 · Cited by 49 · see citing works
Heterodimerization of G-protein-coupled receptors in the CNS
Marshall, F. H. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00001-7 · Cited by 49 · see citing works
Kuzmin, A., Johansson, B. A., Giménez‐Llort, L., Ögren, S. O., & Fredholm, B. B. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.07.001 · Cited by 48 · see citing works
Cauli, O., Pinna, A., Valentini, V., & Morelli, M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300240 · Cited by 48 · see citing works
Popoli, P. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00144-x · Cited by 45 · see citing works
Spealman, R. D. (1988) · Psychopharmacology · doi:10.1007/bf00212759 · Cited by 42 · see citing works
Immunohistochemical localization of caffeine-induced c-Fos protein expression in the rat brain
Bennett, H. J., & Semba, K. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19981109)401:1 · Cited by 41 · see citing works
Adenosine receptor expression and function in rat striatal cholinergic interneurons
Preston, Z., Lee, K., Widdowson, L., Freeman, T. C., Dixon, A. K., & Richardson, P. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703366 · Cited by 40 · see citing works
Brockwell, N. T., & Beninger, R. J. (1996) · Behavioural Pharmacology · doi:10.1097/00008877-199608000-00009 · Cited by 39 · see citing works
Behavioral effects of adenosine analogs in squirrel monkeys: relation to adenosine A2 receptors
Spealman, R. D., & Coffin, V. L. (1986) · Psychopharmacology · doi:10.1007/bf00179203 · Cited by 37 · see citing works
Adenosine receptors--the role in modulation of dopamine and glutamate release in the rat striatum.
Gołembiowska, K., & Żylewska, A. (1998) · PubMed · Cited by 35 · see citing works
Ferré, S., Rimondini, R., Popoli, P., Reggio, R., Pèzzola, A., Hansson, A. C., Andersson, A., & Fuxé, K. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00810.x · Cited by 32 · see citing works
Self-citationPsychostimulants and Vesicle Trafficking: A Novel Mechanism and Therapeutic Implications
Hanson, G. R., Sandoval, V., Riddle, E. L., & Fleckenstein, A. E. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.019 · Cited by 31 · see citing works
Adenosinergic modulation of the discriminative-stimulus effects of methamphetamine in rats
Munzar, P., Justinová, Z., Kutkat, S. W., Ferré, S., & Goldberg, S. R. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1075-5 · Cited by 31 · see citing works
Self-citationHow habitual caffeine consumption and dose influence flavour preference conditioning with caffeine
Tinley, E. M., Durlach, P. J., & Yeomans, M. R. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.03.018 · Cited by 23 · see citing works
Myers, K. P., & Izbicki, E. V. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.05.010 · Cited by 23 · see citing works
Caffeine-reinforced conditioned flavor preferences in rats.
Fedorchak, P. M., Mesita, J., Plater, S. A., & Brougham, K. (2002) · Behavioral Neuroscience · doi:10.1037/0735-7044.116.2.334 · Cited by 19 · see citing works
Reneman, L., de Bruin, K. M., Lavalaye, J., Gunning, W. B., & Booij, J. (2001) · Synapse · doi:10.1002/1098-2396(20010301)39:3 · Cited by 16 · see citing works
Flagged first, then by citations
1 of the 129 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- [46]46. Gine ´s S., Hillion J., Torvinen M. et al. (2000) Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc. Natl Acad. Sci. USA 97, 8606-8611.
- [121]121. Svenningsson P., Lindskog M., Ledent C., Parmentier M., Greengard P., Fredholm B. B. and Fisone G. (2000) Regulation of the phos- phorylation of the dopamine-and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc. Natl Acad. Sci. USA 97, 1856-1860.
Cited by
Sorted by citations
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola, V., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C. (2008) · Science · doi:10.1126/science.1164772 · Cited by 1,786 · see citing works
Heckman, M. A., Weil, J., & de Mejı́a, E. G. (2010) · Journal of Food Science · doi:10.1111/j.1750-3841.2010.01561.x · Cited by 1,072 · see citing works
“The blockage of adenosine to the neurons causes the sleep promoting effects of adenosine to stop, resulting in the neurons speeding up instead of slowing down (Ferre 2008).”
BackgroundKennedy, D. O., & Wightman, E. L. (2011) · Advances in Nutrition · doi:10.3945/an.110.000117 · Cited by 684 · see citing works
“Similarly, in mammals, caffeine is a competitive antagonist of inhibitory adenosine A1 and A2 receptors, which in turn leads to activation via increased dopaminergic and glutamatergic activity (64).”
BackgroundInterindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Nehlig, A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014407 · Cited by 632 · see citing works
Scientific Opinion on the safety of caffeine
EFSA Panel on Dietetic Products, N. A. A. (. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.4102 · Cited by 613 · see citing works
“Prolonged administration of an adenosine A2A receptor antagonist does not induce tolerance to its motor stimulant effect, suggesting that caffeine tolerance may be dependent on blockade of A1, rather than A2A, receptors (Ferre, 2008).”
BackgroundRibeiro, J. A., & Sebastião, A. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1379 · Cited by 584 · see citing works
“Caffeine improves cognition [1]; however, it also affects sleep [3].”
Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance
Davis, J. M., Murphy, E. A., Carmichael, M. D., & Davis, B. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90925.2008 · Cited by 486 · see citing works
“Quercetin, like caffeine, has been shown to be an adenosine A1 receptor antagonist in vitro (1), which is at least partially responsible for the psychostimulant and ergogenic effects of caffeine (1, 5, 7, 9).”
BackgroundAdenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419 · see citing works
Heckman, M. A., Sherry, K., & de Mejı́a, E. G. (2010) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/j.1541-4337.2010.00111.x · Cited by 384 · see citing works
“The blockage of adenosine to the neurons causes the sleep promoting effects of adenosine to stop, resulting in the neurons speeding up instead of slowing down (Ferre 2008).”
BackgroundThe effect of caffeine on subsequent sleep: A systematic review and meta-analysis
Gardiner, C., Weakley, J., Burke, L. M., Roach, G. D., Sargent, C., Maniar, N., Townshend, A., & Halson, S. L. (2023) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2023.101764 · Cited by 315 · see citing works
Genetics of caffeine consumption and responses to caffeine
Yang, A., Palmer, A. A., & de Wit, H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1900-1 · Cited by 310 · see citing works
“The psychomotor stimulant effects of caffeine are due to antagonism of adenosine's inhibitory actions on the striatal D 2 transmission (Ferre 2008).”
Adenosine Receptors and the Central Nervous System
Sebastião, A. M., & Ribeiro, J. A. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-89615-9_16 · Cited by 271 · see citing works
“The broad caffeine intake associated with common beverages, together with the impact of xanthines on biomedical research, prompted many studies that have focused on specific caffeine effects rather than using it as a tool to antagonize ARs (Daly 2007; Ferré 2008).”
BackgroundInfluentialCoffee, Caffeine, and Risk of Depression Among Women
Lucas, M. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.393 · Cited by 270 · see citing works
“Caffeine affects brain function mainly by its antagonist action on the adenosine A2A receptor and, therefore, plays a role in the modulation of dopaminergic transmission.(30,33) The antagonist effect of caffeine on adenosine also might imply nondopaminergic mechanisms, such as modulation of the release of acetylcholin…”
BackgroundCaffeine, Mental Health, and Psychiatric Disorders
Lara, D. R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1378 · Cited by 236 · see citing works
“dopamine, glutamate, and acetylcholine [4,5].”
Cunha, R. A., & Agostinho, P. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1408 · Cited by 233 · see citing works
“Furthermore, evidence is accumulating suggesting that the chronic consumption of caffeine mostly acts by antagonizing A2A rather than A1 receptors [107,108], as first suggested by Daly and Fredholm [58].”
BackgroundCornelis, M. C., Monda, K. L., Yu, K., Paynter, N., Azzato, E. M., Bennett, S. N., Berndt, S. I., Boerwinkle, E., Chanock, S., Chatterjee, N., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002033 · Cited by 228 · see citing works
“Genetic association studies focused on candidate genes related to the pharmacokinetic and pharmacodynamic properties of caffeine have identified genes encoding cytochrome P-450 (CYP)1A2, as the primary enzyme involved in caffeine metabolism [3,4].”
Caffeine as an Attention Enhancer: Reviewing Existing Assumptions
Einöther, S. J. L., & Giesbrecht, T. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2917-4 · Cited by 215 · see citing works
“Caffeine is the single most widely consumed psychoactive ingredient (Ferre 2008).”
Caffeine Use Disorder: A Comprehensive Review and Research Agenda
Meredith, S. E., Juliano, L. M., Hughes, J. R., & Griffiths, R. R. (2013) · Journal of Caffeine Research · doi:10.1089/jcr.2013.0016 · Cited by 210 · see citing works
“Importantly, caffeine has been shown to stimulate dopaminergic activity by removing the negative modulatory effects of adenosine at dopamine receptors.(28) Studies suggest that dopamine release in the nucleus accumbens shell may be a specific neuropharmacological mechanism underlying the addictive potential of caffein…”
BackgroundMechanisms of the psychostimulant effects of caffeine: implications for substance use disorders
Ferré, S. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4212-2 · Cited by 209 · see citing works
“2006) and postsynaptic A1 receptors that form heteromers with D1 receptors in the GABAergic striato-nigral neuron (Ferré et al. 1997; Ferré 2008).”
BackgroundSelf-citationRivera-Oliver, M., & Díaz‐Ríos, M. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.01.083 · Cited by 204 · see citing works
“Caffeine has been described to have the ability to influence dopaminergic neurotransmission and potentiate dopamine receptor-mediated behavioral responses, such as locomotion and cognitive functions (Ferré, 2008; Xie et al., 2007).”
BackgroundInfluentialPotential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
Cunha, R. A., Ferré, S., Vaugeois, J., & Chen, J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480090 · Cited by 187 · see citing works
“Regarding the dopaminergic involvement in schizophrenia, it is noteworthy that activation of adenosine A2A receptors reduces the affinity of dopaminergic D2 receptors for dopamine, being the probable mechanism underlying the antipsychotic-like profile of adenosine agonists [213], the hyperdopaminergic effect of caffei…”
BackgroundSelf-citationCaffeine consumption and self-assessed stress, anxiety, and depression in secondary school children
Richards, G., & Smith, A. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115612404 · Cited by 179 · see citing works
“Dose-dependent effects of caffeine on behaviour Short-term effects of caffeine consumption include enhanced mood and alertness (Ferré, 2008; Kaplan et al., 1997; Lorist and Tops, 2003), improved exercise performance (Doherty and Smith, 2004), increased blood pressure (Riksen et al., 2009), improved…”
BackgroundNon-pharmacological cognitive enhancement
Dresler, M., Sandberg, A., Ohla, K., Bublitz, C., Trenado, C., Mroczko-Wąsowicz, A., Kühn, S., & Repantis, D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.002 · Cited by 181 · see citing works
“Caffeine is an adenosine receptor antagonist; it reduces inhibition of neural firing by large through an increased turnover of noradrenaline in the brain (Smith et al., 2003; Ferre, 2008).”
BackgroundCoffee and caffeine consumption and depression: a meta-analysis of observational studies
Wang, L., Shen, X., Wu, Y., & Zhang, D. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415603131 · Cited by 180 · see citing works
“Second, caffeine, as a nonspecific adenosine A1/ A2A receptor antagonist, generates psychostimulant effects through modulating dopaminergic transmission(Ferre, 2008; Morelli et al., 2010), and major metabolites of caffeine act on adenosine receptors in the brain (Morelli et al.”
BackgroundAdenosine receptor antagonists including caffeine alter fetal brain development in mice
Silva, C. G., Métin, C., Fazeli, W., Machado, N. J., Darmopil, S., Launay, P.-S., Ghestem, A., Nesa, M.-P., Bassot, E., Szabó, E., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006258 · Cited by 177 · see citing works
“A2ARs may control the migration of GABA neurons Chronic consumption of caffeine exerts its central action mostly via its antagonistic action onA2ARs (27, 28).”
BackgroundG protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
Wong, T., Li, G., Li, S., Gao, W., Chen, G., Gan, S., Zhang, M., Li, H., Wu, S., & Du, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01427-2 · Cited by 168 · see citing works
“The psychoactive function of caffeine is mediated via the non-selective antagonistic action on A1/A2A receptors.(144) How A1/A2A receptors regulate depression-like behaviour remains unclear.”
BackgroundBonaventura, J., Navarro, G., Casadó-Anguera, V., Azdad, K., Rea, W. P., Moreno, E., Brugarolas, M., Mallol, J., Canela, E. I., Lluı́s, C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507704112 · Cited by 149 · see citing works
“It has been hypothesized that the allosteric interactions between A2AR and D2R agonists within the A2AR-D2R heteromer provide a mechanism responsible not only for the depressant effects of A2AR agonists, but also for the psychostimulant effects of adenosine A2AR antagonists and the nonselective adenosine receptor anta…”
BackgroundSelf-citationThe Dietary Flavonoid Quercetin Increases VO2max and Endurance Capacity
Davis, J. M., Carlstedt, C. J., Chen, S., Carmichael, M. D., & Murphy, E. A. (2010) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.20.1.56 · Cited by 146 · see citing works
“Quercetin, like caffeine, is an adenosine-A1-receptor antagonist, at least in vitro (Alexander), and the delay in fatigue that occurs with caffeine results at least in part from its ability to block adenosine receptors in the brain (Davis et al., 2003; Ferre, 2008).”
BackgroundEspinosa, J., Rocha, A., Nunes, F., Costa, M. S., Schein, V., Kazlauckas, V., Kalinine, E., Souza, D., Cunha, R., & Porciúncula, L. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-111982 · Cited by 136 · see citing works
“Another major argument to dismiss this hypothesis is the observation that chronic caffeine mostly affects central adenosine A2A receptors (A2AR) [35, 61], which do not seem Fig.”
BackgroundMingote, S., Font, L., Farrar, A. M., Vontell, R., Worden, L. T., Stopper, C. M., Port, R. G., Sink, K. S., Bunce, J. G., Chrobak, J. J., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1525-08.2008 · Cited by 141 · see citing works
Botton, P. H., Costa, M. S., Ardais, A. P., Mioranzza, S., Souza, D. O., da Rocha, J. B. T., & Porciúncula, L. O. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.05.034 · Cited by 140 · see citing works
Adenosine Receptor Control of Cognition in Normal and Disease
Chen, J. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00012-x · Cited by 137 · see citing works
Role of the Central Ascending Neurotransmitter Systems in the Psychostimulant Effects of Caffeine
Ferré, S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1400 · Cited by 133 · see citing works
“[3,22]) Particularly influential were the experiments with A2A receptor knockout (A2AKO) mice, which showed a lack of motor-activating effects of caffeine [49].”
Self-citationAntioxidants in Sport Nutrition
Lamprecht, M. (2014) · CRC Press eBooks · doi:10.1201/b17442 · Cited by 133 · see citing works
Pardo, M., López‐Cruz, L., Valverde, O., Ledent, C. A., Baqi, Y., Müller, C. E., Salamone, J. D., & Correa, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.033 · Cited by 128 · see citing works
Alhaider, I. A., Aleisa, A. M., Tran, T. T., & Alkadhi, K. A. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.02.006 · Cited by 127 · see citing works
da Costa, M. S., Botton, P. H. S., Mioranzza, S., Souza, D. O., & Porciúncula, L. O. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.03.038 · Cited by 124 · see citing works
Pandolfo, P., Machado, N. J., Köfalvi, A., Takahashi, R. N., & Cunha, R. A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.011 · Cited by 118 · see citing works
López‐Cruz, L., Salamone, J. D., & Correa, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00526 · Cited by 117 · see citing works
“Caffeine actions on A1 and A2A adenosine receptors (Ferré, 2008), has promoted its study as an alternative preventive or therapeutic tool for parkinsonian symptoms (Prediger, 2010).”
BackgroundPham, N. M., Nanri, A., Kurotani, K., Kuwahara, K., Kume, A., Sato, M., Hayabuchi, H., & Mizoue, T. (2013) · Public Health Nutrition · doi:10.1017/s1368980013000360 · Cited by 115 · see citing works
“Finally, caffeine can increase excitatory neurotransmitters through modulating dopaminergic transmission((11)) and facilitate the release of acetylcholine and serotonin((12)).”
Drosophila D1 dopamine receptor mediates caffeine-induced arousal
Waldowski, R. A., Kim, Y.-C., Jones, F. S., Han, K., & Greenspan, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806776105 · Cited by 109 · see citing works
“CAFF acting through AdoR on dopaminergic neurons could stimulate dopamine synthesis or release through protein kinase A dependent mechanisms similar to the A2A receptor in mammals (4).”
BackgroundKhadrawy, Y. A., Salem, A. M. H., El-Shamy, K. A., Ahmed, E. K., Fadl, N. N., & Hosny, E. N. (2017) · Journal of Dietary Supplements · doi:10.1080/19390211.2016.1275916 · Cited by 106 · see citing works
“Caffeine, 1,3,7-trimethylxanthine, is the world’s most consumed psychoactive substance (Ferre´, 2008).”
BackgroundSalamone, J. D., Farrar, A. M., Font, L., Patel, V. B., Schlar, D. E., Nunes, E. J., Collins, L. E., & Sager, T. N. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.02.021 · Cited by 105 · see citing works
“Furthermore, the modest effects of caffeine are consistent with reports indicating that caffeine, despite its some-what mixed pattern of binding to adenosine receptors, does show some degree of preference for adenosine A1 receptors over A2A receptors [23].”
BackgroundPsychopharmacology of theobromine in healthy volunteers
Baggott, M. J., Childs, E., Hart, A. B., de Bruin, E. A., Palmer, A. A., Wilkinson, J. E., & de Wit, H. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3021-0 · Cited by 106 · see citing works
“The highest dose of theobromine decreased alertness and increased response times on the ANT task.”
MethodInfluentialCook, C. J., Crewther, B. T., Kilduff, L. P., Drawer, S., & Gaviglio, C. M. (2011) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-8-2 · Cited by 104 · see citing works
Lucas, M., O’Reilly, E. J., Pan, A., Mirzaei, F., Willett, W. C., Okereke, O. I., & Ascherio, A. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.795243 · Cited by 103 · see citing works
“Caffeine has complex effects in the central nervous system, largely mediated by antagonism of adenosine A2a and A1 receptors, including an increased turnover of several monoamine transmitters, such as serotonin, dopamine, and noradrenaline (Fredholm et al. 1999; Ferre 2008; Ferre et al. 2008).”
BackgroundAllosteric mechanisms within the adenosine A2A–dopamine D2 receptor heterotetramer
Ferré, S., Bonaventura, J., Tomasi, D. G., Navarro, G., Moreno, E., Cortés, A., Lluı́s, C., Casadó, V., & Volkow, N. D. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.028 · Cited by 99 · see citing works
“…effects of adenosine analogues and for the psychostimulant effects of selective adenosine A2AR antagonists and the non-selective adenosine receptor antagonist caffeine, with implications for several neuropsychiatric disorders (Ferré et al., 2004, 2008; Ferré, 2008; Bonaventura et al., 2015).”
BackgroundSelf-citationFerré, S., Bonaventura, J., Zhu, W., Hatcher-Solis, C., Taura, J., Quiroz, C., Cai, N.-S., Moreno, E., Casadó-Anguera, V., Kravitz, A. V., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00243 · Cited by 100 · see citing works
“…in the A2AR-D2R heteromer, a reduction in the affinity of agonists for the D2R, contradicts the hypothesis of a key role of allosteric interactions within the A2AR-D2R heteromer as a main mechanism involved in the opposite behavioral effects of A2AR agonists and antagonists (Ferré, 2008, 2016).”
BackgroundSelf-citationTuning and Fine-Tuning of Synapses with Adenosine
Sebastião, A. M., & Ribeiro, J. A. (2009) · Current Neuropharmacology · doi:10.2174/157015909789152128 · Cited by 97 · see citing works
“This A2A/D2 interaction seems to be essential for the behavioural effects of adenosine agonists and antagonists, like caffeine [56].”
BackgroundKim, J., & Kim, J. (2018) · Nutrients · doi:10.3390/nu10091201 · Cited by 95 · see citing works
“Caffeine is well known to have psychostimulant effects [35].”
BackgroundThe Role of Adenosine Receptors in Psychostimulant Addiction
Ballesteros-Yáñez, I., Castillo, C. A., Merighi, S., & Gessi, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00985 · Cited by 80 · see citing works
“CREB phosphorylation then increases transcription of immediate early genes such as c-fos and other genes like preproenkephalin (Ferré, 2008).”
BackgroundInvolvement of Adenosine A2A Receptors in Depression and Anxiety
Yamada, K., Kobayashi, M., & Kanda, T. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00015-5 · Cited by 93 · see citing works
“itor at concentrations higher than the physiological conditions (Ferré, 2008).”
BackgroundNunes, E. J., Randall, P. A., Santerre, J. L., Given, A. M., Sager, T. N., Correa, M., & Salamone, J. D. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.068 · Cited by 91 · see citing works
Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors
Froestl, W., Muhs, A., & Pfeifer, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121186 · Cited by 91 · see citing works
“neurotransmission [374].”
Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans
Orrù, M., Guitart, X., Karcz‐Kubicha, M., Solinas, M., Justinová, Z., Barodia, S. K., Zanoveli, J. M., Cortés, A., Lluı́s, C., Casadó, V., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.029 · Cited by 89 · see citing works
“It is generally believed that caffeine exerts psychostimulant effects acting as a nonselective adenosine A1 receptor (A1R) and A2A receptor (A2AR) antagonist (Fredholm and Persson 1982; Nehlig et al., 1992; Fredholm and Lindstrom, 1999; Fisone et al., 2004; Ferré, 2008).”
BackgroundSelf-citationAdenosine and related drugs in brain diseases: present and future in clinical trials.
Lopes, L. V., Sebastião, A., & Ribeiro, J. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795347591 · Cited by 94 · see citing works
“A2A receptor reduces affinity for dopamine D2 receptors [123, 124]”
BackgroundCaffeine promotes wakefulness via dopamine signaling in Drosophila
Nall, A. H., Shakhmantsir, I., Cichewicz, K., Birman, S., Hirsh, J., & Sehgal, A. (2016) · Scientific Reports · doi:10.1038/srep20938 · Cited by 85 · see citing works
Gonçalves, N., Simões, A., Cunha, R. A., & de Almeida, L. P. (2013) · Annals of Neurology · doi:10.1002/ana.23866 · Cited by 90 · see citing works
Caffeine and seizures: A systematic review and quantitative analysis.
Koert, R. R. V., Bauer, P., Schuitema, I., Sander, J. W., & Visser, G. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.11.003 · Cited by 79 · see citing works
“Chronic administration of caffeine does not affect seizure susceptibility as strongly as acute administration[3,16–26,29,30,45,46,49,57], suggesting the development of tolerance to A1- and A2Areceptor blockade by caffeine.[45,54,56,58,64,100,104] Chronic or acute administration of caffeine did not affect the sensitivi…”
Silva, A. C., Lemos, C., Gonçalves, F. Q., Pliássova, A., Machado, N. J., Silva, H. B. L., Canas, P. M., Cunha, R. A., Lopes, J. P., & Agostinho, P. M. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.024 · Cited by 85 · see citing works
Alhaider, I. A., Aleisa, A. M., Tran, T. T., & Alkadhi, K. A. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07175.x · Cited by 84 · see citing works
“Caffeine, a commonly used central nervous system stimulant (Nicholson & Stone, 1980; Nehlig et al., 1992; Ferre, 2008), is an important pharmacological research tool for studying the involvement of adenosine receptors in cognitive function (Kopf et al., 1999; Dall’ Igna et al., 2004).”
BackgroundXu, K., Luca, D. G. D., Orrù, M., Xu, Y., Chen, J., & Schwarzschild, M. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.035 · Cited by 84 · see citing works
“Several studies have indicated that caffeine exerts its psychostimulant effects acting as a nonselective adenosine A1R and A2AR receptor antagonist (Fredholm and Persson, 1982; Nehlig et al., 1992; Fredholm and Lindström, 1999; Fisone et al., 2004; Ferré, 2008).”
BackgroundEhlers, A., Marakis, G. N., Lampen, A., & Hirsch‐Ernst, K. I. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.05.028 · Cited by 82 · see citing works
Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity
Beharry, K. D. A., Valencia, G. B., Lazzaro, D. R., & Aranda, J. V. (2016) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.12.006 · Cited by 82 · see citing works
“Caffeine also stimulates dopaminergic activity by removing the negative modulatory effects of adenosine at dopamine receptors.(112) Caffeine was first demonstrated to be effective for treatment of apnea of prematurity (AOP) in the 1970s by Aranda et al.”
Jin, M.-J., Yoon, C.-H., Ko, H., Kim, H.-M., Kim, A., Moon, H., & Jung, S.-P. (2016) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2016.37.2.111 · Cited by 80 · see citing works
Astrocyte regulation of synaptic signaling in psychiatric disorders
Kruyer, A., Kalivas, P. W., & Scofield, M. D. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01338-w · Cited by 76 · see citing works
“Gi-coupled A1 and Gs-coupled A2A adenosine receptors have received the most attention for their regulation of synaptic physiology in recent years [95, 107, 108].”
BackgroundWei, Y., Xu, J., Miao, S., Wei, K., Peng, L., Wang, Y., & Wei, X. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2048291 · Cited by 73 · see citing works
Acute effects of tea consumption on attention and mood
Einöther, S. J. L., & Martens, V. E. G. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.058248 · Cited by 74 · see citing works
“Caffeine is present in a range of beverages (eg, tea, coffee, soft drinks, energy drinks) and in some foods (eg, chocolate) and is the most consumed psychoactive ingredient worldwide (24).”
BackgroundA comparison of the effects of caffeine following abstinence and normal caffeine use
Addicott, M. A., & Laurienti, P. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1668-3 · Cited by 69 · see citing works
“At normal dietary concentrations, caffeine produces a mild neurostimulant effect by antagonizing adenosine, thus disinhibiting neuronal firing throughout the brain (for review, see Nehlig 1999; Ferre 2008).”
BackgroundAdenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome
Quiroz, C., Gulyani, S., Ruiqian, W., Bonaventura, J., Cutler, R. G., Pearson, V., Allen, R. P., Earley, C. J., Mattson, M. P., & Ferré, S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.002 · Cited by 69 · see citing works
“…A1R could be involved in the pathogenesis of PLMS in RLS. Postsynaptic A1R form heteromers with D1R and their activation or blockade leads to a respective selective decrease or increase in D1R-mediated activation of D1R-expressing striato-nigral neurons (Ferré et al., 1997; Ferré, 2008, 2010).”
BackgroundSelf-citationThe effect of caffeine on working memory load-related brain activation in middle-aged males
Klaassen, E. B., de Groot, R. H. M., Evers, E. A. T., Snel, J., Veerman, E. C. I., Ligtenberg, A. J. M., Jolles, J., & Veltman, D. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.026 · Cited by 68 · see citing works
“This finding is consistent with both the neurostimulant and arousal enhancing effects on caffeine primarily via the dopamine (Ferre, 2008; Pelligrino et al., 2010) and histaminergic arousal (Ferre, 2008) systems respectively.”
BackgroundResultInfluentialHuntley, E. D., & Juliano, L. M. (2011) · Psychological Assessment · doi:10.1037/a0026417 · Cited by 69 · see citing works
Kaufling, J., Waltisperger, E., Bourdy, R., Valera, A. M., Veinante, P., Freund‐Mercier, M. J., & Barrot, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00984.x · Cited by 66 · see citing works
“Due to caffeine’s low affinity for phophodiesterases, its in vivo action, particularly its psychostimulant effect, is thought to be mediated through its inhibitory effects on adenosine receptors (Ferré, 2008).”
BackgroundAdenosine A2A Receptors in Psychopharmacology: Modulators of Behavior, Mood and Cognition
Shen, H., & Chen, J. (2009) · Current Neuropharmacology · doi:10.2174/157015909789152191 · Cited by 66 · see citing works
“The activation of A2ARs can reduce D2R affinity and function, which may potentially underlie the antipsychotic-like profile of adenosine agonists [56], the hyperdopaminergic effect of caffeine [53, 56] and the exacerbation of psychotic symptoms by caffeine in schizophrenic patients [132].”
BackgroundCaffeine triggers behavioral and neurochemical alterations in adolescent rats
Ardais, A. P., Borges, M. F., da Rocha, A. S., Sallaberry, C., Cunha, R. A., & Porciúncula, L. O. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.003 · Cited by 64 · see citing works
“…adenosine receptor antagonist with similar in vitro affinities for A1 receptors (A1R) and A2AR (Fredholm et al., 1999), the main adenosine receptors involved in memory normalization (Cunha and Agostinho, 2010) and in the motor-activating, reinforcing and arousal effects of this drug (Ferré, 2008).”
Hagen, E. H., Roulette, C. J., & Sullivan, R. J. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00142 · Cited by 64 · see citing works
“interacts with the central dopaminergic systems via antagonism of endogenous adenosine (135).”
BackgroundDiukova, A., Ware, J. J., Smith, J. E., Evans, J., Murphy, K., Rogers, P. J., & Wise, R. G. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.04.041 · Cited by 64 · see citing works
“In addition, y, Park Place, Cardiff University, license. there is also evidence showing that caffeine has secondary effects on other neurotransmitter systems including dopamine, acetylcholine and noradrenaline (Ferre, 2008; Fredholm et al., 1999; Latini and Pedata, 2001).”
BackgroundInfluentialCaffeine Caused a Widespread Increase of Resting Brain Entropy
Chang, D., Song, D., Zhang, J., Shang, Y., Ge, Q., & Wang, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-21008-6 · Cited by 62 · see citing works
Plant-derived nootropics and human cognition: A systematic review
Lorca, C., Mulet, M., Arévalo‐Caro, C., Sanchez, M. Á., Perez, A., Perrino, M., Bach-Faig, A., Aguilar, A., Vilella, E., Gallart‐Palau, X., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2021137 · Cited by 64 · see citing works
Juliano, L. M., Huntley, E. D., Harrell, P. T., & Westerman, A. T. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.01.009 · Cited by 61 · see citing works
The effects of energy drink in combination with alcohol on performance and subjective awareness
Alford, C., Hamilton-Morris, J., & Verster, J. C. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2677-1 · Cited by 60 · see citing works
“Blockade of the A2A receptor by caffeine inhibits the sleeppromoting effect with adenosine levels increasing across the hours of wakefulness (Davis et al. 2003; Ferré 2008; Huang et al. 2007; Landolt 2008; Sturgess et al. 2010).”
BackgroundInduced Alkalosis and Caffeine Supplementation: Effects on 2,000-m Rowing Performance
Carr, A. J., Gore, C. J., & Dawson, B. (2011) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.21.5.357 · Cited by 72 · see citing works
“Caffeine supplementation can improve short-term (5–10 min) endurance performance (Jackman, Wendling, Friars, & Graham, 1996; Wiles, Bird, & Hopkins, 1992) via enhanced voluntary muscle activation (Ferré, 2008; Kalmar, 2005), reduced rating of perceived exertion (RPE) and pain perception during exercise (Ganio, Klau, C…”
BackgroundManalo, R. V. M., & Medina, P. M. B. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00137 · Cited by 55 · see citing works
“For the most part, its enhancing effects are attributed to the antagonism of adenosine A2A receptors (A2ARs)—ligands of which, like adenosine, bind to induce sleepiness—which may explain the psychostimulatory effects of caffeine (Ferré, 2008a).”
BackgroundResultFerré, S., Díaz-Ríos, M., Salamone, J. D., & Prediger, R. D. (2018) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2018.0017 · Cited by 52 · see citing works
Self-citationRandall, P. A., Nunes, E. J., Janniere, S. L., Stopper, C. M., Farrar, A. M., Sager, T. N., Baqi, Y., Hockemeyer, J., Müller, C. E., & Salamone, J. D. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2198-3 · Cited by 56 · see citing works
“Nonselective adenosine antagonists such as caffeine act as minor stimulants and are commonly consumed by humans drinking coffee, tea, and “energy drinks” (Antoniou et al. 2005; Ferré 2008; Ferré et al. 2008a; Reissig et al. 2009).”
Paiva, I., Cellai, L., Mériaux, C., Poncelet, L., Nebie, O., Saliou, J.-M., Lacoste, A.-S., Papegaey, A., Drobecq, H., Gras, S. L., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci149371 · Cited by 48 · see citing works
Comparison of caffeine-induced locomotor activity between adolescent and adult rats
Marin, M. T., ZANCHETA, R. P., Paro, A. H., Possi, A. P. M., Cruz, F. C., & Planeta, C. S. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.052 · Cited by 55 · see citing works
“In addition, current evidence suggests that the psychostimulant and reinforcing effects of caffeine may be the result of increased activity of dopaminergic neurotransmission, perhaps via adenosine–dopamine interactions (Powell et al., 2001; Ferré, 2008).”
BackgroundDopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia
Lee, H.-Y., Nakayama, J., Xu, Y., Fan, X., Karouani, M., Shen, Y., Pothos, E. N., Hess, E. J., Fu, Y., Edwards, R. H., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58470 · Cited by 55 · see citing works
Genetic susceptibility to caffeine intake and metabolism: a systematic review
Low, J. J.-L., Tan, B. J., Yi, L., Zhou, Z., & Tan, E. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05737-z · Cited by 63 · see citing works
“…adenosine binds to adenosine receptors, adenylyl cyclase and Ca2 + channels are activated, consequently activating the cAMP-PKA signalling pathway, which induces the phosphorylation of dopamine, inhibiting its release, leading to many downstream biological changes in the brain and the CNS , [112].”
BackgroundCoinciding exercise with peak serum caffeine does not improve cycling performance
Skinner, T. L., Jenkins, D. G., Taaffe, D. R., LEVERITT, M. D., & Coombes, J. S. (2012) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2012.04.004 · Cited by 54 · see citing works
Caffeine modulates CREB-dependent gene expression in developing cortical neurons
Connolly, S., & Kingsbury, T. J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.054 · Cited by 54 · see citing works
Li, F., He, F., Ye, X.-J., Shen, W., Wu, Y.-P., Zhai, Y., Wang, X., & Lin, J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.005 · Cited by 52 · see citing works
The impact of daily caffeine intake on nighttime sleep in young adult men
Weibel, J., Lin, Y.-S., Landolt, H.-P., Kistler, J., Rehm, S., Rentsch, K. M., Slawik, H., Borgwardt, S., Cajochen, C., & Reichert, C. F. (2021) · Scientific Reports · doi:10.1038/s41598-021-84088-x · Cited by 52 · see citing works
Ferreira, D. D. P., Stutz, B., Mello, F. G. D., Reis, R. A. D. M., & Kubrusly, R. C. C. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.060 · Cited by 50 · see citing works
“Pharmacological mechanisms underlying caffeine effects are primarily via a nonselective antagonism of adenosine receptors, with A1 and A2A receptors as preferential targets (Fredholm et al., 1999; Ferre, 2008).”
BackgroundModulation of adenosine signaling prevents scopolamine-induced cognitive impairment in zebrafish
Bortolotto, J. W., de Melo, G. M., Cognato, G. D. P., Vianna, M. R. M. R., & Bonan, C. D. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2014.11.016 · Cited by 50 · see citing works
“The psychostimulant effect of caffeine on the central nervous system (CNS) is primarily due to the antagonism of adenosine receptors A1 and A2A (Ferré, 2008; Fredholm, Bättig, Holmén, Nehlig, & Zvartau, 1999).”
BackgroundHsu, C. W., Wang, C. S., & Chiu, T. H. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-4 · Cited by 49 · see citing works
“The anatomical and functional interactions between the adenosine and dopamine receptors in the striatum have been recently reviewed [8-10].”
BackgroundCaviola, L., & Faber, N. S. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01852 · Cited by 47 · see citing works
Poole, R. L., & Tordoff, M. G. (2017) · Journal of Caffeine Research · doi:10.1089/jcr.2016.0030 · Cited by 49 · see citing works
Lu, G., Huang, S., Liu, S., Liu, P., Chou, W., & Lin, W. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.12.004 · Cited by 48 · see citing works
“Caffeine causes a diverse range f pharmacological effects that are time- and concentrationependent and reversible (Ferre et al., 2008; Ferre, 2008; Bode Abbreviations: SR, serine/arginine-rich; ACTN, alpha actinin; KLF6, Krüppel-like actor 6; EMT, epithelial-mesenchymal-transition; HIF-1 , hypoxia…”
BackgroundCaffeine and cognitive performance: Persistent methodological challenges in caffeine research
James, J. E. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.05.019 · Cited by 47 · see citing works
“Caffeine exerts pharmacological actions at diverse sites, both centrally and peripherally, due mostly to antagonism of endogenous adenosine, with A1 and A2A receptors appearing to be the primary targets (Ferré, 2008).”
Background
- Authors
- Ferré, S.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Ferré, Sergi
- ORCID
- Ferré, Sergi
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2007-12-18
- Volume
- 105
- Issue
- 4
- Pages
- 1067-1079
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1994970739
- Cited by
- 440
- References
- 129
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 14 · 2023: 23 · 2022: 31 · 2021: 30 · 2020: 15 · 2019: 26 · 2018: 24 · 2017: 18 · 2016: 32 · 2015: 32 · 2014: 25 · 2013: 34 · 2012: 29
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Drug Abuse
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- caffeine, psychostimulant effects, adenosine receptors, adenosine A1 receptor, adenosine A2A receptor, receptor heteromers, dopamine signaling, glutamatergic synapses, dopamine D1 receptor, dopamine D2 receptor, motor activation, reinforcement, adenosine
- MeSH terms
- Adenosine, Central Nervous System Stimulants, Animals, Caffeine, Humans, Receptors, Purinergic P1, Purinergic P1 Receptor Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review